/DMAA

DMAA Stock - Drugs Made In America Acquisition Corp. Ordinary Shares

Q: What is the analyst price target for DMAA?

Analyst price target information is not currently available for DMAA.

Q: What is DMAA's market cap?

Market capitalization information is not currently available for DMAA.

Financial Services|Shell Companies|NASDAQ

$10.36+0.01%

+$0.00 (+0.01%) • Dec 19

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

HOLD

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $11.40

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for DMAA

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2024

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta2.67

52W High$10.37

52W Low$9.95

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2024
Revenue	N/A
Gross Profit	N/A
Gross Margin	N/A
Operating Income	$-479
Net Income	$-479
Net Margin	N/A
EPS	$-0.06

Company Overview

Drugs Made In America Acquisition Corp. operates as a blank check company. The Company aims to acquire one and more businesses and assets, via a merger, capital stock exchange, asset acquisition, stock purchase, and reorganization.

Visit Website

Frequently Asked Questions about DMAA

What is DMAA's current stock price?

Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA) is currently trading at $10.36 per share. The stock has moved +0.01% today.

What is the analyst price target for DMAA?

No analyst price targets are currently available for this stock.

What sector is Drugs Made In America Acquisition Corp. Ordinary Shares in?

Drugs Made In America Acquisition Corp. Ordinary Shares operates in the Financial Services sector, specifically within the Shell Companies industry. The company is traded on the NASDAQ exchange.

What is DMAA's market cap?

Drugs Made In America Acquisition Corp. Ordinary Shares has a market capitalization of $0.35 billion, making it a small-cap company.

Does DMAA pay dividends?

No, Drugs Made In America Acquisition Corp. Ordinary Shares does not currently pay a dividend to shareholders.